1.14.13.154: erythromycin 12-hydroxylase
This is an abbreviated version!
For detailed information about erythromycin 12-hydroxylase, go to the full flat file.
Word Map on EC 1.14.13.154
-
1.14.13.154
-
editing
-
inosine
-
a-to-i
-
deaminases
-
deamination
-
symmetrica
-
hereditaria
-
dyschromatosis
-
rna-editing
-
rna-specific
-
adenosine-to-inosine
-
interferon-inducible
-
ifn-inducible
-
glur-b
-
site-selective
-
zalpha
-
left-handed
-
adar2-mediated
-
hypopigmented
-
dsrbds
-
recoding
-
hyperediting
-
synthesis
-
macules
-
z-dna-binding
-
genodermatosis
-
dsrna-binding
- 1.14.13.154
-
editing
- inosine
-
a-to-i
- deaminases
-
deamination
-
symmetrica
-
hereditaria
-
dyschromatosis
-
rna-editing
-
rna-specific
-
adenosine-to-inosine
-
interferon-inducible
-
ifn-inducible
-
glur-b
-
site-selective
-
zalpha
-
left-handed
-
adar2-mediated
-
hypopigmented
-
dsrbds
-
recoding
-
hyperediting
- synthesis
-
macules
-
z-dna-binding
-
genodermatosis
-
dsrna-binding
Reaction
Synonyms
CYP113A1, EryK, erythromycin C-12 hydroxylase
ECTree
1.14.13.154 erythromycin 12-hydroxylaseAdvanced search results
results (
results (Results
in table
51
Crystallization
Crystallization on EC 1.14.13.154 - erythromycin 12-hydroxylase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top
CRYSTALLIZATION (Commentary) 
ORGANISM
UNIPROT
LITERATURE
crystal structures of EryK in complex with the azole inhibitors ketoconazole and clotrimazole
different crystal forms are harvested from distinct crystallization conditions: two ligand-free forms, one substrate bound and two inhibitors-bound. All crystals belong either to the monoclinc P2(1)or to the orthorhombic P2(1)2(1)2(1) space groups, and exhibit diffraction limits ranging from 2.3 to 1.6 A
vapor diffusion at 21°C, three crystal forms of EryK are obtained in different crystallization conditions: with His tag (His6-EryK) in low salt conditions, without tag (EryK) in high salt, and in complex with its substrate erythromycin D (ErD-EryK)
